Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Apr 05, 2024 $46.59 $50.78 $45.83 $50.24 927 746
Apr 04, 2024 $47.55 $49.50 $47.04 $47.08 554 437
Apr 03, 2024 $46.48 $47.50 $45.71 $47.08 580 948
Apr 02, 2024 $46.03 $46.70 $45.24 $46.59 804 392
Apr 01, 2024 $46.74 $47.04 $45.72 $46.97 561 255
Mar 28, 2024 $46.91 $47.12 $46.28 $46.69 433 953
Mar 27, 2024 $45.97 $47.16 $45.55 $46.82 520 976
Mar 26, 2024 $45.98 $46.24 $45.01 $45.46 350 723
Mar 25, 2024 $45.87 $46.31 $45.04 $45.42 436 813
Mar 22, 2024 $46.81 $47.05 $45.56 $45.85 397 824
Mar 21, 2024 $47.34 $47.94 $46.63 $46.65 468 879
Mar 20, 2024 $46.94 $47.26 $46.35 $47.01 516 790
Mar 19, 2024 $46.11 $47.37 $46.11 $47.00 880 411
Mar 18, 2024 $47.94 $47.94 $46.53 $46.59 739 242
Mar 15, 2024 $46.61 $47.63 $46.22 $47.37 1 720 919
Mar 14, 2024 $47.85 $48.07 $46.48 $46.65 1 046 084
Mar 13, 2024 $47.82 $49.27 $47.60 $48.55 833 398
Mar 12, 2024 $48.26 $48.76 $47.32 $47.66 548 825
Mar 11, 2024 $50.66 $50.95 $48.40 $48.51 639 185
Mar 08, 2024 $51.42 $51.73 $50.16 $50.53 490 259
Mar 07, 2024 $51.65 $52.09 $50.49 $50.85 534 528
Mar 06, 2024 $51.42 $51.77 $50.89 $51.26 435 070
Mar 05, 2024 $52.62 $53.25 $50.14 $51.47 790 576
Mar 04, 2024 $53.76 $53.77 $52.01 $53.31 661 791
Mar 01, 2024 $52.23 $54.55 $52.03 $53.69 727 263
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT